Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.61 |
| ▸ | TSHR | P16473 | 1/20 | 0.61 |
| ▸ | MAPT | P10636 | 1/20 | 0.61 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.61 |
| ▸ | HBB | P68871 | 1/20 | 0.61 |
| ▸ | PYGM | P11217 | 3/20 | 0.57 |
| ▸ | P2RY6 | Q15077 | 2/20 | 0.55 |
| ▸ | P2RY14 | Q15391 | 2/20 | 0.55 |
| ▸ | NT5E | P21589 | 1/20 | 0.55 |
| ▸ | TK2 | O00142 | 2/20 | 0.53 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.48 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.48 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.48 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.48 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.46 |
| ▸ | DNPH1 | O43598 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6820209 | 1.00 | LMNA (0.61) | LMNASMN1; SMN2TSHRMAPTPMP22 | |
| SCHEMBL6820198 | 1.00 | LMNA (0.61) | LMNASMN1; SMN2TSHRMAPTPMP22 | |
| SCHEMBL21423107 | 0.90 | LMNA (0.59) | LMNASMN1; SMN2TSHRMAPTPMP22 | |
| SCHEMBL5968261 | 0.90 | LMNA (0.59) | LMNASMN1; SMN2TSHRMAPTPMP22 | |
| SCHEMBL10888417 | 0.90 | LMNA (0.59) | LMNASMN1; SMN2TSHRMAPTPMP22 | |
| SCHEMBL23590367 | 0.90 | LMNA (0.59) | LMNASMN1; SMN2TSHRMAPTPMP22 | |
| SCHEMBL4736899 | 0.90 | LMNA (0.59) | LMNASMN1; SMN2TSHRMAPTPMP22 | |
| 5-Fluorouridine SCHEMBL11756887 | 0.90 | PYGM (0.70) | LMNASMN1; SMN2TSHRMAPTPMP22 | |
| 5-Fluorouridine SCHEMBL21423048 | 0.90 | PYGM (0.70) | LMNASMN1; SMN2TSHRMAPTPMP22 | |
| 5-Fluorouridine SCHEMBL329381 | 0.90 | PYGM (0.70) | LMNASMN1; SMN2TSHRMAPTPMP22 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040063651-A1 | Remedies for hepatitis c | MITSUBISHI PHARMA CORPORATION (JP) | 2004-04-01 | — | — | US | claimed |
| EP-1346724-A1 | REMEDIES FOR HEPATITIS C | Mitsubishi Pharma Corporation (JP) | 2003-09-24 | — | — | EP | claimed |
| JP-62242624-A | — | — | None | — | — | JP | disclosed |
| US-20040063651-A1 | Remedies for hepatitis c | MITSUBISHI PHARMA CORPORATION (JP) | 2004-04-01 | — | — | US | disclosed |
| EP-1346724-A1 | REMEDIES FOR HEPATITIS C | Mitsubishi Pharma Corporation (JP) | 2003-09-24 | — | — | EP | disclosed |
| JP-S62242624-A | ANTITUMOR AGENT | ASAHI GLASS CO LTD | 1987-10-23 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040063651-A1 | Remedies for hepatitis c | UPP1, UMPS, UNG | LMNA 1944/4885SMN1; SMN2 3112/4885TSHR 3957/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.